CpG-ODN Attenuates Pathological Cardiac Hypertrophy and Heart Failure by Activation of PI3Kα-Akt Signaling

Phosphoinositide-3-kinase α (PI3Kα) represents a potential novel drug target for pathological cardiac hypertrophy (PCH) and heart failure. Oligodeoxynucleotides containing CpG motifs (CpG-ODN) are classic agonists of Toll-like receptor 9 (TLR9), which typically activates PI3K-Akt signaling in immune...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Yang, Liang, Cai, Xiangyu, Liu, Jie, Jia, Zhe, Jiao, Jinjin, Zhang, Jincai, Li, Changlin, Li, Jing, Tang, Xiang D.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3640052/
https://ncbi.nlm.nih.gov/pubmed/23638055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0062373
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares